Cargando…
Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways
BACKGROUND: Resveratrol (RSV) has attracted interest as an alternative drug for the treatment of acute lung injury (ALI) and other pulmonary diseases, but its poor oral bioavailability is a limitation. In this study, we employed drug delivery nanotechnology to improve the stability, lung localizatio...
Autores principales: | de Oliveira, Maria Talita Pacheco, de Sá Coutinho, Diego, Tenório de Souza, Éverton, Stanisçuaski Guterres, Sílvia, Pohlmann, Adriana Raffin, Silva, Patricia Machado Rodrigues, Martins, Marco Aurélio, Bernardi, Andressa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636190/ https://www.ncbi.nlm.nih.gov/pubmed/31371957 http://dx.doi.org/10.2147/IJN.S200666 |
Ejemplares similares
-
Resveratrol-Loaded Lipid-Core Nanocapsules Modulate Acute Lung Inflammation and Oxidative Imbalance Induced by LPS in Mice
por: de Oliveira, Maria Talita Pacheco, et al.
Publicado: (2021) -
Pequi (Caryocar brasiliense Cambess)-Loaded Nanoemulsion, Orally Delivered, Modulates Inflammation in LPS-Induced Acute Lung Injury in Mice
por: de Sá Coutinho, Diego, et al.
Publicado: (2020) -
Labeling the oily core of nanocapsules and lipid-core nanocapsules with a triglyceride conjugated to a fluorescent dye as a strategy to particle tracking in biological studies
por: Fiel, Luana Almeida, et al.
Publicado: (2014) -
α-bisabolol-loaded lipid-core nanocapsules reduce lipopolysaccharide-induced pulmonary inflammation in mice
por: D’Almeida, Ana Paula L, et al.
Publicado: (2017) -
The Anti-Arthritic Activity of Diclofenac Lipid-Core Nanocapsules: Stereological Analysis Showing More Protection of Deep Joint Components
por: Ureña, Nathalie Marte, et al.
Publicado: (2023)